Related Experiment Video
Updated: Aug 2, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Prospective study in 142 cases of hepatitis C virus infection
Wen-Mei Fan1, Wan-Fu Zhu, Li-Min Yin
1Department of Microbiology, School of Basic Medicine, Health Science Center, Peking University, Beijing 100083, China. zhuwanfu@sun.bjmu.edu.cn
Insights
Hepatitis C virus (HCV) infection in Chinese blood donors shows a high chronicity rate (83.58%) over nine years. Co-infection with Hepatitis B virus (HBV) and alcohol use increase liver disease progression risk.
Area of Science:
- Hepatology
- Virology
- Public Health
Background:
- Limited data exists on the natural history of Hepatitis C Virus (HCV) infection in China.
- Understanding long-term outcomes and risk factors is crucial for developing effective prevention and treatment strategies.
Purpose of the Study:
- To investigate the nine-year outcome of HCV infection in Chinese blood donors.
- To identify risk factors associated with HCV chronicity and disease progression.
Main Methods:
- Follow-up of 142 anti-HCV positive blood donors in Hebei Province from 1993 to 2002 without antiviral treatment.
- Detection of anti-HCV, HCV-RNA, aminotransferase levels, and genotyping using restriction fragment length polymorphism (RFLP).
- Assessment of age, sex, alcohol consumption, and clinical symptoms; B-mode ultrasound for liver assessment.
Main Results:
- A high rate of chronicity (83.58%) and a spontaneous viral resolution rate of 16.42% were observed.
- HCV genotypes 1b, 2a, and 1b/2a were predominant.
- Elevated ALT, AST, and gamma-GT levels were significantly higher in HCV-RNA positive cases. Male donors showed a higher abnormal ALT/AST rate. Super-infection with HBV and excessive alcohol consumption were linked to increased progression.
Conclusions:
- Hebei Province exhibits a high chronicity rate for HCV infection.
- Preventive measures are essential to curb progression to severe liver diseases, particularly in cases of HCV/HBV super-infection.
Aim:
There is limited information on the natural history of HCV infection in China. We investigated the outcome of HCV infection after nine-year follow-up and the risk factors in blood donors in China in order to provide the foundation for prevention and therapy.
Methods:
A total of 172 cases of HCV infection with anti-HCV positive and ALT abnormality were enrolled in the archives when was screened blood in Hebei Province in 1993. In them 142 blood donors were followed up till July 2002. No antiviral treatment was applied to them during the period of infection. In the present study, anti-HCV, HCV-RNA and aminotransferase were detected and genotyping was conducted by the method of restriction fragment length polymorphism(RFLP). B-type ultrasound detection was performed in all the patients. Age, sex, alcohol consumption and clinical symptoms were questioned.
Results:
After nine years' follow-up, 10.56% (15/142) of the cases were negative for anti-HCV and 16.42% (12/134) of them were negative for HCV-RNA. The genotypes 1b, 2a and 1b/2a were 91.07%, 6.25% and 2.68% respectively. Twelve cases (8.45%) were negative for both HCV RNA and anti-HCV. The rate of chronicity in this group was 83.58% (112/134), and the rate of viral spontaneous resolution was 16.42% (22/134). The mean level of ALT, AST, gamma-GT in HCV RNA positive cases was significantly higher than that in HCV RNA negative cases (P<0.001). The abnormal rate of ALT and/or AST in male donors was significantly higher than that in female donors (P = 0.005). The rate of progression to liver cirrhosis from chronic hepatitis C was significantly higher in the cases of super-infection with HBV than that in the cases of single HCV infection. Overdose alcohol consumption promoted the progression to chronicity.
Conclusion:
This area (Hebei Province) has a higher rate of chronicity in HCV infection, and measures should be taken to prevent its progression to serious liver diseases, especially for patients super-infected with HCV and HBV.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
04:11Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA
Published on: December 15, 2023
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction